Stifel Downgrades Orthofix Medical to Hold, Lowers Price Target to $16
Portfolio Pulse from Benzinga Newsdesk
Stifel analyst Mathew Blackman has downgraded Orthofix Medical (NASDAQ:OFIX) from Buy to Hold and lowered the price target from $30 to $16.

September 12, 2023 | 3:59 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Orthofix Medical has been downgraded from Buy to Hold by Stifel analyst Mathew Blackman, with the price target also being lowered from $30 to $16.
The downgrade from Buy to Hold indicates a less optimistic outlook for the company's stock, which could lead to a decrease in demand and potentially a lower stock price. The lowering of the price target from $30 to $16 also suggests that the analyst believes the stock is overvalued at its current price, which could further discourage investment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100